Eleclazine (GS-6615) is a novel and selective voltage-gated sodium channel inhibitor with antiarrhythmic properties that reduces peak sodium current (INaP) recorded from human induced pluripotent stem cell-derived cardiomyocytes.
Molekulargewicht:
415.37
Reinheit:
98.67%
CAS Nummer:
[1443211-72-0]
Formel:
C21H16F3N3O3
Target-Kategorie:
Sodium Channel|||Potassium Channel
T71945
T71945
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten